Aurora Spine (ASG) Lytham Partners Spring 2025 Investor Conference summary

Executive backgrounds

• CEO has over 25 years in spine and ortho-neuro markets, with experience at multiple industry leaders.

• CCO has commercialized five groundbreaking technologies and is focused on market expansion.

Product innovation and portfolio

• Focus on minimally invasive spine surgery technologies for outpatient centers, covering the full spine.

• Key products include ZIP, DEXA, Silo, Silo TFX, Osteo Onyx, and the newly FDA-approved AERO system.

Sales strategy and team expansion

• Transitioned to a hybrid sales model with over 15 direct reps and a strong distributor network.

• Regional directors support both direct and distributor sales, aiming for national coverage by year-end.

• Recent hires in the Mid-Atlantic and Great Lakes regions; about two-thirds of the U.S. is covered.

• Plans to thoughtfully scale the team, adding more reps in high-performing markets.